$4.12
+0.07 (+1.73%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+191.7% upside
Low Target
$8.98
Average Target
$12.02
High Target
$15.27
Current Price
$4.12
Current
$4.12
$4.12
Target
$12.02
$12.02
$8.98
$12.02 avg
$15.27
Scenario Analysis
Bear Case
$8.98
118.0%
Low target
Base Case
$12.02
+191.7%
Avg target
Bull Case
$15.27
+270.6%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$8.84
-53.4% from high
52-Week Low
$3.88
+6.2% from low
Target vs 52W High
$12.02
+36.0% vs high
Next Earnings Report
Nov 10, 2026 · After Market Close
2d
until earnings
EPS Est: $-0.81
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals